Incannex Healthcare Inc

IXHLNASDAQ · USD
3.32USD0.00 (-2.36%)
812

Incannex Healthcare Inc (IXHL) Expected Move

IXHL expected move through Oct 16, 2026 is 249.2%, with 19 days to expiration. The implied range is -$4.96 to $11.60, based on the previous trading day's options prices.

Read more

Tracking the IXHL expected move helps you see how far Incannex Healthcare Inc's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Incannex Healthcare Inc's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the IXHL expected move for this week's options, in real time.

The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For IXHL, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The IXHL expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Incannex Healthcare Inc is unlikely to go.

Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases.

It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea; and Monash Trauma Group at the Department of Neuroscience, Monash University to conduct a study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Sydney, Australia.

Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the IXHL expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Incannex Healthcare Inc expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about IXHL.

IXHL Price

EARN
EM

Drag chart to pan. Drag axes to zoom.

ExpirationDTEExpected move (USD)Expected move (%)Upper priceLower price
Oct 16, 202619$8.28249.2%$11.60-$4.96
Nov 20, 202654$7.30219.9%$10.62-$3.98
Dec 18, 202682$5.99180.3%$9.31-$2.67
Mar 19, 2027173$9.85296.7%$13.17-$6.53

As of September 25, 2026

Know What the Market Expects From IXHL

Track the IXHL expected move across every expiration, filter by IV rank and liquidity, and trade around the range the market is already pricing in.

Start your 14-day free trial